VIVAX MALARIA
Clinical trials for VIVAX MALARIA explained in plain language.
Never miss a new study
Get alerted when new VIVAX MALARIA trials appear
Sign up with your email to follow new studies for VIVAX MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a short drug course end malaria relapses for good?
⭐️ CURE ⭐️ CompletedThis study tested how well the drug primaquine prevents the return of P. vivax malaria in 160 adults. Participants had uncomplicated malaria and normal G6PD levels. The goal was to see if a short treatment could stop relapses, aiming for a complete cure.
Matched conditions: VIVAX MALARIA
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
New short-course malaria cure could save thousands
⭐️ CURE ⭐️ CompletedThis study tested a new way to cure vivax malaria, a type of malaria that can come back. Researchers gave a high daily dose of the drug primaquine for a short time, but only after a quick test to check for a genetic condition (G6PD deficiency) that could cause serious side effect…
Matched conditions: VIVAX MALARIA
Phase: NA • Sponsor: Menzies School of Health Research • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
New Short-Course malaria treatment could prevent relapses
Disease control CompletedThis study tested a new approach to treat vivax malaria, a type that can hide in the liver and come back. Researchers used a quick test to check for a genetic condition (G6PD deficiency) that can cause dangerous side effects with the standard drug primaquine. Then, they gave a hi…
Matched conditions: VIVAX MALARIA
Phase: NA • Sponsor: Macfarlane Burnet Institute for Medical Research and Public Health Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC